Oxford’s COVID-19 research receives government funding

Three Oxford-based COVID-19 projects are among the first to benefit from a share of £20 million in government investment. The three projects include work on an effective vaccine, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale. Another project will examine how existing treatments could be repurposed to treat coronavirus. Business Secretary Alok Sharma said, 'Whether testing new drugs or examining how to repurpose existing ones, UK scientists and researchers have been working tirelessly on the development of treatments for coronavirus. The projects we are funding today will be vital in our work to support our valuable NHS and protect people's lives.' Health Secretary Matt Hancock said, 'In the midst of a global health emergency the UK is using all its extensive research expertise to quickly develop new vaccines to target this international threat. This investment will speed up globally-recognised vaccine development capabilities and help us find a new defence against this disease.' The projects receiving funding are supporting and encouraging the UK's world-class researchers and experts to speed up coronavirus research including developing new vaccines and treatments. Oxford's funded projects are: Professor Sarah Gilbert, University of Oxford - £2.2 million for vaccine development and trials The team are already developing a new vaccine against the COVID-19, as they initiated vaccine development as soon as the genetic sequence of the novel coronavirus was released.